Management of Iron Deficiency Anemia with Ongoing Bleeding

Immediate Treatment Recommendation

In patients with iron deficiency anemia and ongoing bleeding, intravenous iron sucrose should be used as first-line therapy while simultaneously identifying and treating the bleeding source, as oral iron is unlikely to keep pace with ongoing blood loss, according to the American Gastroenterological Association 1, 2

For gastrointestinal angioectasias, endoscopic ablation with argon plasma coagulation is first-line therapy, though monotherapy is often insufficient, and adjunct medical therapy with IV iron as maintenance should be added to increase hemoglobin, decrease transfusion requirements, and reduce hospital admissions, as recommended by the American Gastroenterological Association 1, 3
In patients with hereditary hemorrhagic telangiectasia, IV iron should be considered first-line in patients with severe anemia or when oral replacement is expected to be inadequate, according to the American Society of Hematology 4

Oral iron absorption is limited to 10-20 mg/day maximum, while ongoing GI bleeding can exceed 30-50 mg/day of iron loss, making IV iron sucrose a more effective treatment option, as stated by the American Gastroenterological Association 2
In patients with ongoing bleeding from angioectasias, IV iron serves as essential adjunct therapy even when endoscopic treatment is performed, according to the American Gastroenterological Association 1, 3

Do not continue oral iron indefinitely when ongoing bleeding is present, as oral absorption cannot match ongoing losses, and do not delay IV iron while pursuing extensive GI investigation, as recommended by the American Gastroenterological Association 2
Do not use endoscopic monotherapy alone for angioectasias, as adjunct medical therapy with IV iron is essential given high rebleeding rates, according to the American Gastroenterological Association 1, 3